EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical implications and current perspectives of statin-induced rhabdomyolysis syndrome – case presentation

Elena Cosmina Ciobanu, Andreea Simona Ungurenasu, Mihai Ștefan Cristian Haba, Antoniu Octavian Petris, Ovidiu Mitu

Romanian Journal of Cardiology · 2022

DOI: 10.2478/rjc-2022-0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Cardiology, 2022. Verfasst von Elena Cosmina Ciobanu und 4 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Though rare, statins can produce serious adverse effects with clinical implications that urge prompt intervention. However, in high-risk patients that require intense hypolipemiant treatment, such situations can be challenging and require complimentary therapies. We report the case of a 82-year-old hypertensive female patient admitted for diffuse myalgia, mainly in the lower limbs, fatigue and shortness of breath. The patient is known with a recent myocardial infarction (MI) treated by primary stent implantation. The electrocardiogram and transthoracic echocardiography confirmed the recent MI, with non-dilated left ventricle mildly reduced ejection fraction. Initial laboratory studies revealed elevated NT-proBNP, moderate renal impairment and increased serum levels of creatine kinase (CK), CK-MB fraction and transaminases. After stopping statin and receiving supportive treatment, the patient's paraclinical test results and symptoms improved: CK levels and transaminase dropped significantly and both myalgia and general fatigue resolved mostly within 4 days. PCSK9 inhibitor has been introduced with favourable results at follow-ups. Even though statins are effective and safe, they may still generate potential dangerous adverse effects in rare cases. Statin dose adjustment or replacement and adding other lipid lowering therapies represent current therapeutical options, especially in high-risk populations.

Zitieren

APA

Ciobanu, E. C., Ungurenasu, A. S., Haba, M. Ș. C., Petris, A. O., & Mitu, O. (2022). Clinical implications and current perspectives of statin-induced rhabdomyolysis syndrome – case presentation. Romanian Journal of Cardiology. https://doi.org/10.2478/rjc-2022-0009

Vancouver

Ciobanu EC, Ungurenasu AS, Haba MȘC, Petris AO, Mitu O. Clinical implications and current perspectives of statin-induced rhabdomyolysis syndrome – case presentation. Romanian Journal of Cardiology. 2022. doi:10.2478/rjc-2022-0009

BibTeX
@article{Ciobanu2022,
  author = {Ciobanu, Elena Cosmina and Ungurenasu, Andreea Simona and Haba, Mihai Ștefan Cristian and Petris, Antoniu Octavian and Mitu, Ovidiu},
  title = {Clinical implications and current perspectives of statin-induced rhabdomyolysis syndrome – case presentation},
  journal = {Romanian Journal of Cardiology},
  year = {2022},
  doi = {10.2478/rjc-2022-0009}
}
Kostenlos starten →